Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.

Cancer Med · 2024 · PMC10904968 · PMID 38327130

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

borderline significancep = 0.072so close (0.05 < p ≤ 0.1)

Other factors significantly associated with survival outcomes were age >74 years old for OS (HR: 8.512) and no pCR for MFS (HR: 2.223) and RFS (HR: 2.057), with borderline significance ( p = 0.072 and p = 0.084, respectively).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.